BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -39.6%, against -24.2% the year before. The highest annual figure on record is 54.5% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -39.6% | −15.4 |
| FY2024 | Dec 31, 2024 | -24.2% | −48.5 |
| FY2023 | Dec 31, 2023 | 24.4% | −30.1 |
| FY2022 | Dec 31, 2022 | 54.5% | +0.3 |
| FY2021 | Dec 31, 2021 | 54.2% | +51.1 |
| FY2020 | Dec 31, 2020 | 3.2% | +168.1 |
| FY2019 | Dec 31, 2019 | -164.9% | −127.3 |
| FY2018 | Dec 31, 2018 | -37.6% | +101.4 |
| FY2017 | Dec 31, 2017 | -139.1% | – |
See a number that looks wrong?